The main side effects are nausea, vomiting, diarrhea, and headaches, Paulvin says
Syringes and alcohol pads included
Orforglipron is a wildcard Foundayo (orforglipron), a once-daily oral small-molecule GLP-1 receptor agonist that Lilly licensed from Chugai in 2018, could remake the leaderboard in 2026
Sona is a board-certified internist and endocrinologist
As an Add-on to Metformin Monotherapy The reduction in HbA1c in T2DM patients on metformin monotherapy with SGLT2i + DPP4i FDCs is compared in Table 3
Common reasons Dose too low - may need to increase to therapeutic levels (2.4mg or higher) Not enough time - meaningful results typically take 8-12 weeks at adequate doses Calorie-dense liquid calories bypassing satiety signals - watch smoothies, alcohol, sugary drinks Eating through fullness signals - pay attention to your body's cues Inconsistent dosing schedule - must be same day each week for optimal levels Unrealistic expectations - 1-2 lbs per week is healthy, sustainable weight loss Key Research [1]"Once-weekly cagrilintide for weight management in people with overweight and obesity" Lau DCW et al., 2021 Finding: Phase 2 trial showed cagrilintide at 4.5mg achieved 10.8% weight loss versus 3% with placebo over 26 weeks in 706 participants